Cargando…

Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer

BACKGROUND: Muscle invasive bladder cancer (MIBC) remains amongst the deadliest genitourinary malignancies due to treatment failure and extensive molecular heterogeneity, delaying effective targeted therapeutics. Hypoxia and nutrient deprivation, oversialylation and O-glycans shortening are salient...

Descripción completa

Detalles Bibliográficos
Autores principales: Peixoto, Andreia, Ferreira, Dylan, Azevedo, Rita, Freitas, Rui, Fernandes, Elisabete, Relvas-Santos, Marta, Gaiteiro, Cristiana, Soares, Janine, Cotton, Sofia, Teixeira, Beatriz, Paulo, Paula, Lima, Luís, Palmeira, Carlos, Martins, Gabriela, Oliveira, Maria José, Silva, André M. N., Santos, Lúcio Lara, Ferreira, José Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188679/
https://www.ncbi.nlm.nih.gov/pubmed/34108014
http://dx.doi.org/10.1186/s13046-021-01988-6
_version_ 1783705372904652800
author Peixoto, Andreia
Ferreira, Dylan
Azevedo, Rita
Freitas, Rui
Fernandes, Elisabete
Relvas-Santos, Marta
Gaiteiro, Cristiana
Soares, Janine
Cotton, Sofia
Teixeira, Beatriz
Paulo, Paula
Lima, Luís
Palmeira, Carlos
Martins, Gabriela
Oliveira, Maria José
Silva, André M. N.
Santos, Lúcio Lara
Ferreira, José Alexandre
author_facet Peixoto, Andreia
Ferreira, Dylan
Azevedo, Rita
Freitas, Rui
Fernandes, Elisabete
Relvas-Santos, Marta
Gaiteiro, Cristiana
Soares, Janine
Cotton, Sofia
Teixeira, Beatriz
Paulo, Paula
Lima, Luís
Palmeira, Carlos
Martins, Gabriela
Oliveira, Maria José
Silva, André M. N.
Santos, Lúcio Lara
Ferreira, José Alexandre
author_sort Peixoto, Andreia
collection PubMed
description BACKGROUND: Muscle invasive bladder cancer (MIBC) remains amongst the deadliest genitourinary malignancies due to treatment failure and extensive molecular heterogeneity, delaying effective targeted therapeutics. Hypoxia and nutrient deprivation, oversialylation and O-glycans shortening are salient features of aggressive tumours, creating cell surface glycoproteome fingerprints with theranostics potential. METHODS: A glycomics guided glycoproteomics workflow was employed to identify potentially targetable biomarkers using invasive bladder cancer cell models. The 5637 and T24 cells O-glycome was characterized by mass spectrometry (MS), and the obtained information was used to guide glycoproteomics experiments, combining sialidase, lectin affinity and bottom-up protein identification by nanoLC-ESI-MS/MS. Data was curated by a bioinformatics approach developed in-house, sorting clinically relevant molecular signatures based on Human Protein Atlas insights. Top-ranked targets and glycoforms were validated in cell models, bladder tumours and metastases by MS and immunoassays. Cells grown under hypoxia and glucose deprivation disclosed the contribution of tumour microenvironment to the expression of relevant biomarkers. Cancer-specificity was validated in healthy tissues by immunohistochemistry and MS in 20 types of tissues/cells of different individuals. RESULTS: Sialylated T (ST) antigens were found to be the most abundant glycans in cell lines and over 900 glycoproteins were identified potentially carrying these glycans. HOMER3, typically a cytosolic protein, emerged as a top-ranked targetable glycoprotein at the cell surface carrying short-chain O-glycans. Plasma membrane HOMER3 was observed in more aggressive primary tumours and distant metastases, being an independent predictor of worst prognosis. This phenotype was triggered by nutrient deprivation and concomitant to increased cellular invasion. T24 HOMER3 knockdown significantly decreased proliferation and, to some extent, invasion in normoxia and hypoxia; whereas HOMER3 knock-in increased its membrane expression, which was more pronounced under glucose deprivation. HOMER3 overexpression was associated with increased cell proliferation in normoxia and potentiated invasion under hypoxia. Finally, the mapping of HOMER3-glycosites by EThcD-MS/MS in bladder tumours revealed potentially targetable domains not detected in healthy tissues. CONCLUSION: HOMER3-glycoforms allow the identification of patients’ subsets facing worst prognosis, holding potential to address more aggressive hypoxic cells with limited off-target effects. The molecular rationale for identifying novel bladder cancer molecular targets has been established. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-01988-6.
format Online
Article
Text
id pubmed-8188679
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81886792021-06-10 Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer Peixoto, Andreia Ferreira, Dylan Azevedo, Rita Freitas, Rui Fernandes, Elisabete Relvas-Santos, Marta Gaiteiro, Cristiana Soares, Janine Cotton, Sofia Teixeira, Beatriz Paulo, Paula Lima, Luís Palmeira, Carlos Martins, Gabriela Oliveira, Maria José Silva, André M. N. Santos, Lúcio Lara Ferreira, José Alexandre J Exp Clin Cancer Res Research BACKGROUND: Muscle invasive bladder cancer (MIBC) remains amongst the deadliest genitourinary malignancies due to treatment failure and extensive molecular heterogeneity, delaying effective targeted therapeutics. Hypoxia and nutrient deprivation, oversialylation and O-glycans shortening are salient features of aggressive tumours, creating cell surface glycoproteome fingerprints with theranostics potential. METHODS: A glycomics guided glycoproteomics workflow was employed to identify potentially targetable biomarkers using invasive bladder cancer cell models. The 5637 and T24 cells O-glycome was characterized by mass spectrometry (MS), and the obtained information was used to guide glycoproteomics experiments, combining sialidase, lectin affinity and bottom-up protein identification by nanoLC-ESI-MS/MS. Data was curated by a bioinformatics approach developed in-house, sorting clinically relevant molecular signatures based on Human Protein Atlas insights. Top-ranked targets and glycoforms were validated in cell models, bladder tumours and metastases by MS and immunoassays. Cells grown under hypoxia and glucose deprivation disclosed the contribution of tumour microenvironment to the expression of relevant biomarkers. Cancer-specificity was validated in healthy tissues by immunohistochemistry and MS in 20 types of tissues/cells of different individuals. RESULTS: Sialylated T (ST) antigens were found to be the most abundant glycans in cell lines and over 900 glycoproteins were identified potentially carrying these glycans. HOMER3, typically a cytosolic protein, emerged as a top-ranked targetable glycoprotein at the cell surface carrying short-chain O-glycans. Plasma membrane HOMER3 was observed in more aggressive primary tumours and distant metastases, being an independent predictor of worst prognosis. This phenotype was triggered by nutrient deprivation and concomitant to increased cellular invasion. T24 HOMER3 knockdown significantly decreased proliferation and, to some extent, invasion in normoxia and hypoxia; whereas HOMER3 knock-in increased its membrane expression, which was more pronounced under glucose deprivation. HOMER3 overexpression was associated with increased cell proliferation in normoxia and potentiated invasion under hypoxia. Finally, the mapping of HOMER3-glycosites by EThcD-MS/MS in bladder tumours revealed potentially targetable domains not detected in healthy tissues. CONCLUSION: HOMER3-glycoforms allow the identification of patients’ subsets facing worst prognosis, holding potential to address more aggressive hypoxic cells with limited off-target effects. The molecular rationale for identifying novel bladder cancer molecular targets has been established. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-01988-6. BioMed Central 2021-06-09 /pmc/articles/PMC8188679/ /pubmed/34108014 http://dx.doi.org/10.1186/s13046-021-01988-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Peixoto, Andreia
Ferreira, Dylan
Azevedo, Rita
Freitas, Rui
Fernandes, Elisabete
Relvas-Santos, Marta
Gaiteiro, Cristiana
Soares, Janine
Cotton, Sofia
Teixeira, Beatriz
Paulo, Paula
Lima, Luís
Palmeira, Carlos
Martins, Gabriela
Oliveira, Maria José
Silva, André M. N.
Santos, Lúcio Lara
Ferreira, José Alexandre
Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
title Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
title_full Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
title_fullStr Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
title_full_unstemmed Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
title_short Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
title_sort glycoproteomics identifies homer3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188679/
https://www.ncbi.nlm.nih.gov/pubmed/34108014
http://dx.doi.org/10.1186/s13046-021-01988-6
work_keys_str_mv AT peixotoandreia glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT ferreiradylan glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT azevedorita glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT freitasrui glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT fernandeselisabete glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT relvassantosmarta glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT gaiteirocristiana glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT soaresjanine glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT cottonsofia glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT teixeirabeatriz glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT paulopaula glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT limaluis glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT palmeiracarlos glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT martinsgabriela glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT oliveiramariajose glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT silvaandremn glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT santosluciolara glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer
AT ferreirajosealexandre glycoproteomicsidentifieshomer3asapotentiallytargetablebiomarkertriggeredbyhypoxiaandglucosedeprivationinbladdercancer